Cambridge Investment Research Advisors, Inc. - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 37 filers reported holding AIM IMMUNOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2023$9
-40.0%
20,340
-56.4%
0.00%
Q4 2022$15
-99.9%
46,679
-1.1%
0.00%
Q3 2022$27,000
-25.0%
47,178
+1.1%
0.00%
Q2 2022$36,000
-26.5%
46,6780.0%0.00%
Q1 2022$49,000
-47.9%
46,678
-0.0%
0.00%
Q3 2021$94,000
-6.0%
46,6790.0%0.00%
Q2 2021$100,000
-5.7%
46,6790.0%0.00%
-100.0%
Q1 2021$106,000
+45.2%
46,679
+14.7%
0.00%
Q4 2020$73,0000.0%40,679
+19.0%
0.00%
Q3 2020$73,00034,1790.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2020
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders